Literature DB >> 15451497

Microbiology and drug resistance mechanisms of fully resistant pathogens.

Fiona M Walsh1, Sebastian G B Amyes.   

Abstract

The acquisition of vancomycin resistance by Gram-positive bacteria and carbapenem resistance by Gram-negative bacteria has rendered some hospital-acquired pathogens impossible to treat. The resistance mechanisms employed are sophisticated and very difficult to overcome. Unless alternative treatment regimes are initiated soon, our inability to treat totally resistant bacteria will halt other developments in medicine. In the community, Gram-positive bacteria responsible for pneumonia could become totally resistant leading to increased mortality from this common infection, which would have a more immediate impact on our current lifestyles.

Entities:  

Mesh:

Year:  2004        PMID: 15451497     DOI: 10.1016/j.mib.2004.08.007

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  16 in total

1.  Targeting Enterococcus faecalis biofilms with phage therapy.

Authors:  Leron Khalifa; Yair Brosh; Daniel Gelman; Shunit Coppenhagen-Glazer; Shaul Beyth; Ronit Poradosu-Cohen; Yok-Ai Que; Nurit Beyth; Ronen Hazan
Journal:  Appl Environ Microbiol       Date:  2015-02-06       Impact factor: 4.792

2.  Interactions of antibiotics and extracts of Helichrysum pedunculatum against bacteria implicated in wound infections.

Authors:  O A Aiyegoro; A J Afolayan; A I Okoh
Journal:  Folia Microbiol (Praha)       Date:  2010-05-19       Impact factor: 2.099

3.  Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.

Authors:  Michelle M Butler; John D Williams; Norton P Peet; Donald T Moir; Rekha G Panchal; Sina Bavari; Dean L Shinabarger; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

4.  Aerosolized antimicrobial agents based on degradable dextran nanoparticles loaded with silver carbene complexes.

Authors:  Cátia Ornelas-Megiatto; Parth N Shah; Peter R Wich; Jessica L Cohen; Jasur A Tagaev; Justin A Smolen; Brian D Wright; Matthew J Panzner; Wiley J Youngs; Jean M J Fréchet; Carolyn L Cannon
Journal:  Mol Pharm       Date:  2012-10-19       Impact factor: 4.939

5.  Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria.

Authors:  Catalin Iancu; Aoife Grainger; Des Field; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Probiotics Antimicrob Proteins       Date:  2012-06       Impact factor: 4.609

6.  The yefM-yoeB toxin-antitoxin systems of Escherichia coli and Streptococcus pneumoniae: functional and structural correlation.

Authors:  Concha Nieto; Izhack Cherny; Seok Kooi Khoo; Mario García de Lacoba; Wai Ting Chan; Chew Chieng Yeo; Ehud Gazit; Manuel Espinosa
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490

Review 7.  Structure, function, and evolution of bacterial ATP-binding cassette systems.

Authors:  Amy L Davidson; Elie Dassa; Cedric Orelle; Jue Chen
Journal:  Microbiol Mol Biol Rev       Date:  2008-06       Impact factor: 11.056

8.  Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics.

Authors:  Juan David Guzman; Abraham Wube; Dimitrios Evangelopoulos; Antima Gupta; Antje Hüfner; Chandrakala Basavannacharya; Md Mukhleshur Rahman; Christina Thomaschitz; Rudolf Bauer; Timothy Daniel McHugh; Irene Nobeli; Jose M Prieto; Simon Gibbons; Franz Bucar; Sanjib Bhakta
Journal:  J Antimicrob Chemother       Date:  2011-05-28       Impact factor: 5.790

9.  Antibacterial activity of some selected medicinal plants of Pakistan.

Authors:  Yamin Bibi; Sobia Nisa; Fayyaz M Chaudhary; Muhammad Zia
Journal:  BMC Complement Altern Med       Date:  2011-06-30       Impact factor: 3.659

10.  A screening for antimicrobial activities of Caribbean herbal remedies.

Authors:  Claribel Luciano-Montalvo; Isabelle Boulogne; Jannette Gavillán-Suárez
Journal:  BMC Complement Altern Med       Date:  2013-06-04       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.